The 2019 Genitourinary Pathology Society (GUPS) white paper on contemporary grading of prostate cancer

JI Epstein, MB Amin, SW Fine… - … of pathology & …, 2021 - meridian.allenpress.com
Context.—Controversies and uncertainty persist in prostate cancer grading. Objective.—To
update grading recommendations. Data Sources.—Critical review of the literature along with …

Cell plasticity and prostate cancer: The role of epithelial–mesenchymal transition in tumor progression, invasion, metastasis and cancer therapy resistance

S Papanikolaou, A Vourda, S Syggelos, K Gyftopoulos - Cancers, 2021 - mdpi.com
Simple Summary Although epithelial-to-mesenchymal transition (EMT) is a well-known
cellular process involved during normal embryogenesis and wound healing, it also has a …

Molecular biomarkers in localized prostate cancer: ASCO guideline

SE Eggener, RB Rumble, AJ Armstrong… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE This guideline provides recommendations for available tissue-based prostate
cancer biomarkers geared toward patient selection for active surveillance, identification of …

Kaempferol suppresses androgen-dependent and androgen-independent prostate cancer by regulating Ki67 expression

Y Zhang, J Chen, W Fang, K Liang, X Li… - Molecular Biology …, 2022 - Springer
Purpose Kaempferol is a natural flavonoid that has been reported to be active against many
cancers, including prostate cancer, breast cancer and colon cancer. In our previous study …

Novel insights in cell cycle dysregulation during prostate cancer progression

S Ben-Salem, VB Venkadakrishnan… - Endocrine-related …, 2021 - erc.bioscientifica.com
Prostate cancer (CaP) remains the second leading cause of cancer deaths in Western men.
These deaths occur because metastatic CaP acquires resistance to available treatments …

Functions of SMYD proteins in biological processes: What do we know? An updated review

A Rueda-Robles, M Audano… - Archives of Biochemistry …, 2021 - Elsevier
Background Epigenetic modifiers, such as methyltransferases, play crucial roles in the
regulation of many biological processes, including development, cancer and multiple …

The SMYD3-MAP3K2 signaling axis promotes tumor aggressiveness and metastasis in prostate cancer

S Ikram, A Rege, MY Negesse, AG Casanova… - Science …, 2023 - science.org
Aberrant activation of Ras/Raf/mitogen-activated protein kinase (MAPK) signaling is
frequently linked to metastatic prostate cancer (PCa); therefore, the characterization of …

[HTML][HTML] Texture analysis on gadoxetic acid enhanced-MRI for predicting Ki-67 status in hepatocellular carcinoma: A prospective study

Z Ye, H Jiang, J Chen, X Liu, Y Wei, C Xia… - Chinese Journal of …, 2019 - ncbi.nlm.nih.gov
Objective To investigate the value of whole-lesion texture analysis on preoperative
gadoxetic acid enhanced magnetic resonance imaging (MRI) for predicting tumor Ki-67 …

[HTML][HTML] Ki-67 is an independent predictor of prostate cancer death in routine needle biopsy samples: proving utility for routine assessments

SF Kammerer-Jacquet, A Ahmad, H Møller, H Sandu… - Modern Pathology, 2019 - Elsevier
Standard clinical parameters fail to accurately differentiate indolent from aggressive prostate
cancer. Our previous studies showed that immunohistochemical testing for Ki-67 improved …

SMYD3: a regulator of epigenetic and signaling pathways in cancer

BJ Bernard, N Nigam, K Burkitt, V Saloura - Clinical Epigenetics, 2021 - Springer
Chromatin modifiers and their implications in oncogenesis have been an exciting area of
cancer research. These are enzymes that modify chromatin via post-translational …